We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Thomas Polascik

Thomas J. Polascik MD, FACS

Professor of Urology, Director of Focal Therapy, Director of Surgical Technology, Duke Prostate and Urological Cancer Center, Duke University Medical Center, Durham, North Carolina

Dr. Thomas Polascik is a professor of surgery, the director of the Urologic Oncology Program, and the director of the Genitourinary Program on Focal Therapy at Duke Cancer Institute in Durham, North Carolina.

Dr. Polascik received his medical degree from the University of Chicago Pritzker School of Medicine. He did his residency training in general surgery at Johns Hopkins Hospital in Baltimore, Maryland, and in urology at the James Buchanan Brady Urological Institute at Hopkins. He also completed a fellowship in urologic oncology at Johns Hopkins Hospital

His clinical interests include nerve-sparing focal therapy for prostate cancer and minimally invasive surgery for kidney tumors, as well as urologic oncology.